Elite Pharmaceuticals (ELTP) Return on Invested Capital [ROIC] (2009 - 2026)
Elite Pharmaceuticals' Return on Invested Capital [ROIC] was 27.58% in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 15.56 percentage points from 43.14% a year earlier and down 1.60 percentage points from the prior quarter.
Elite Pharmaceuticals (ELTP) Return on Invested Capital [ROIC] (2009 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Return on Invested Capital [ROIC] at Elite Pharmaceuticals came in at 48.11%, up 16.56 percentage points from FY2025.
- Return on Invested Capital [ROIC] has now increased for three consecutive fiscal years, with a five-year change of +48.11 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Invested Capital [ROIC] was 31.55% in FY2025 (+9.08 pp), 22.47% in FY2024 (+11.24 pp), 11.23% in FY2023 (-11.55 pp) and 22.78% in FY2022 (+22.78 pp).
- The fiscal Q2 2027 figure marks the lowest quarterly Return on Invested Capital [ROIC] since fiscal Q3 2025.
- Compared with a year earlier, Return on Invested Capital [ROIC] was higher in six of the last eight quarters, with an average year-over-year change of +11.35 percentage points.
- The best year-over-year quarter for Return on Invested Capital [ROIC] over five years was fiscal Q1 2026 (a gain of 47.78 percentage points); the worst was fiscal Q1 2027 (a drop of 38.79 percentage points).
- Per Business Quant data, ELTP's Return on Invested Capital [ROIC] in the three fiscal quarters before Q2 2027 was 29.19% (Q1 2027), 42.17% (Q4 2026) and 53.59% (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 30.89% |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 17.57% |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 24.28% |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 2.52% |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 22.91% |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 15.60% |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | -6.11% |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 12.34% |
| 10 | Elite Pharmaceuticals | 401.23 Mn | 274.64 Mn | 15.99 Mn | 27.58% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 27.58% |
| Jun 30, 2026 | 29.19% |
| Mar 31, 2026 | 42.17% |
| Dec 31, 2025 | 53.59% |
| Sep 30, 2025 | 43.14% |
| Jun 30, 2025 | 67.98% |
| Mar 31, 2025 | 38.05% |
| Dec 31, 2024 | 25.12% |
| Sep 30, 2024 | 23.17% |
| Jun 30, 2024 | 20.19% |
| Mar 31, 2024 | 18.38% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 11.49% |
| Jun 30, 2023 | 10.94% |
| Mar 31, 2023 | 9.51% |
| Dec 31, 2022 | 11.21% |
| Sep 30, 2022 | 11.93% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
Elite Pharmaceuticals Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();